Literature DB >> 31808489

Identification of the biliary selenium metabolite and the biological significance of selenium enterohepatic circulation.

Kazuaki Takahashi1, Yasumitsu Ogra.   

Abstract

Although selenium (Se) is mainly excreted in urine, it has been reported that an unknown Se metabolite is excreted in bile. When we administered selenomethionine (SeMet), selenocyanate or selenite to rats, a common biliary selenometabolite was detected 10 min after administration. The amount of the selenometabolite originating from SeMet was less than that originating from the two inorganic Se compounds, selenocyanate and selenite, suggesting that the transformation from the methylated organic selenocompound, i.e., SeMet, was less efficient than that from the inorganic Se compounds. The common biliary selenometabolite was concretely identified as selenodiglutathione (GSSeSG) by two types of mass spectrometry, i.e., LC-inductively coupled mass spectrometry (ICP-MS) and LC-ESI-Q/TOF. The bile-drained rats had lower urinary Se levels than the sham-operated rats. In addition, the Se amounts in urine plus bile of the bile-drained rats were comparable to the Se amount in the urine of the sham-operated rats. These results suggest that the biliary selenometabolite, GSSeSG, was reabsorbed in the gut and finally excreted in urine. Enterohepatic circulation occurs to maintain Se status in the body.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31808489     DOI: 10.1039/c9mt00274j

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  3 in total

1.  NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance.

Authors:  Meng-Yu Zhang; Ming Luo; Kai He; Xian-Ming Xia; Jie-Ping Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  FXR expression in rats of hilar cholangiocarcinoma.

Authors:  Meng-Yu Zhang; Ming Luo; Jie-Ping Wang
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis.

Authors:  Mikel Etxebeste-Mitxeltorena; Esther Moreno; Manuela Carvalheiro; Alba Calvo; Iñigo Navarro-Blasco; Elena González-Peñas; José I Álvarez-Galindo; Daniel Plano; Juan M Irache; Antonio J Almeida; Carmen Sanmartín; Socorro Espuelas
Journal:  ACS Infect Dis       Date:  2021-11-12       Impact factor: 5.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.